Doctors Note Logo

Published on: 9/26/2026

How does insulin resistance affect PCOS?

Insulin resistance is present in roughly 65 to 70 percent of people with PCOS, and it worsens the condition by forcing the pancreas to release excess insulin, which signals the ovaries to overproduce androgens such as testosterone while lowering sex hormone binding globulin. That hormonal shift disrupts ovulation and leads to irregular or missing periods, acne, excess facial and body hair, scalp hair thinning, stubborn weight gain around the midsection, dark velvety skin patches, and reduced fertility, while also raising long term risk of prediabetes, type 2 diabetes, high cholesterol, fatty liver, and heart disease. Importantly, insulin resistance can affect people with PCOS at any body size, including those at a normal weight, and several factors influence how strongly it shows up, including genetics, inflammation, sleep, stress, and medications, so see below for the full details before drawing conclusions about your own situation.

Because PCOS symptoms overlap heavily with thyroid disorders, adrenal conditions, and other hormonal issues, guessing can delay the bloodwork and treatment that actually help. Take a free, instant, online symptom check to organize what you are experiencing, understand which possibilities fit your pattern, and walk into your next appointment ready to ask for the right tests.

Last reviewed for medical accuracy: 09/26/2026

answer background

Explanation

How Insulin Resistance Affects PCOS

Polycystic ovary syndrome (PCOS) is a common hormonal disorder affecting up to 10–15% of women of reproductive age. Insulin resistance (IR)—when cells respond poorly to insulin—plays a central role in the development and severity of PCOS. Understanding this connection can help you manage symptoms, reduce long-term risks and improve overall health.

What Is Insulin Resistance?

Insulin is a hormone produced by the pancreas that helps cells absorb glucose (sugar) from the bloodstream for energy. In insulin resistance:

  • Muscle, fat and liver cells fail to respond normally to insulin.
  • The pancreas produces more insulin to compensate (hyperinsulinemia).
  • Blood sugar levels can remain normal for a time but eventually rise, increasing the risk of prediabetes and type 2 diabetes.

Credible sources:
• National Institutes of Health (NIH)
• American Diabetes Association (ADA)

The Link Between Insulin Resistance and PCOS

  1. Hyperinsulinemia Promotes Androgen Production

    • Elevated insulin levels stimulate ovarian theca cells to produce more androgens (male hormones) such as testosterone.
    • High androgen levels disrupt follicle maturation, leading to irregular or absent ovulation.
  2. Reduced Sex Hormone‐Binding Globulin (SHBG)

    • Insulin suppresses hepatic production of SHBG, a protein that binds androgens.
    • Lower SHBG means more free testosterone circulates, worsening symptoms like acne and hirsutism.
  3. Follicular Arrest and Anovulation

    • Excess insulin and androgens impair normal follicle development.
    • This leads to multiple small ovarian cysts and irregular menstrual cycles, hallmark features of PCOS.
  4. Weight Gain and Central Obesity

    • Insulin resistance promotes fat storage, especially around the abdomen.
    • Central obesity further worsens insulin sensitivity, creating a vicious cycle.

Symptoms Exacerbated by Insulin Resistance

Women with PCOS and insulin resistance often experience:

  • Irregular Periods: Oligomenorrhea (infrequent cycles) or amenorrhea (absence of periods).
  • Hirsutism: Excess facial or body hair.
  • Acne: Persistent or adult-onset breakouts.
  • Weight Gain: Difficulty losing weight, especially around the midsection.
  • Skin Changes: Darkened, velvety patches (acanthosis nigricans) in body folds.
  • Fatigue & Mood Swings: Fluctuating blood sugar can affect energy and mood.

Long-Term Health Risks

Untreated insulin resistance in PCOS raises the likelihood of:

  • Type 2 diabetes and metabolic syndrome
  • Dyslipidemia (high triglycerides, low HDL cholesterol)
  • Hypertension and cardiovascular disease
  • Endometrial hyperplasia and cancer (due to chronic anovulation)

Regular monitoring and early intervention can help reduce these risks.

Diagnosing Insulin Resistance in PCOS

No single test definitively diagnoses insulin resistance, but common assessments include:

  • Fasting Insulin & Glucose: A basic snapshot of blood sugar and insulin levels.
  • Oral Glucose Tolerance Test (OGTT): Measures how your body handles a glucose load over 2 hours.
  • HOMA-IR (Homeostatic Model Assessment of Insulin Resistance): Calculates insulin resistance from fasting insulin and glucose values.
  • Acanthosis Nigricans Examination: Physical sign of chronic insulin elevation.

Your doctor may combine lab results with clinical signs and family history to assess risk.

Managing Insulin Resistance in PCOS

  1. Lifestyle Modifications
    • Dietary Changes

    • Emphasize low-glycemic-index carbohydrates (whole grains, non-starchy vegetables).
    • Prioritize lean protein and healthy fats (fish, nuts, olive oil).
    • Spread carbohydrate intake evenly throughout the day.
      • Exercise
    • Aim for 150 minutes per week of moderate aerobic activity (brisk walking, cycling).
    • Include resistance training (light weights or body-weight exercises) 2–3 times weekly.
      • Weight Management
    • Even a 5–10% weight reduction can significantly improve insulin sensitivity and restore ovulation.
  2. Medications
    • Metformin

    • First-line insulin-sensitizer; reduces hepatic glucose production and improves peripheral uptake.
    • May help regulate menstrual cycles and reduce androgen levels.
      • Thiazolidinediones (e.g., pioglitazone)
    • Improve insulin sensitivity; less commonly used due to side effects.
      • Inositol Supplements
    • Myo-inositol and D-chiro-inositol may improve insulin action and ovarian function.
      • GLP-1 Agonists (e.g., liraglutide)
    • Promote weight loss and enhance insulin secretion; often considered in obesity-related PCOS.
  3. Monitoring & Follow-Up

    • Regularly track weight, waist circumference, blood pressure and lipid profile.
    • Reassess glucose tolerance annually or as recommended by your healthcare provider.

When to Seek Further Evaluation

If you experience any of the following, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps:

  • Persistent menstrual irregularities
  • New or worsening signs of high androgens (hirsutism, acne)
  • Significant weight gain despite lifestyle efforts
  • Symptoms of elevated blood sugar (excessive thirst, frequent urination)

Working With Your Healthcare Team

  • Endocrinologist or Gynecologist: For specialized hormone and metabolic care.
  • Registered Dietitian: To create a personalized, PCOS-friendly meal plan.
  • Physical Therapist or Trainer: To develop a safe, sustainable exercise routine.
  • Mental Health Professional: To address stress, anxiety or depression linked to PCOS.

Always speak to a doctor about any symptom that could be life-threatening or seriously impact your health.

Key Takeaways

  • Insulin resistance is central to PCOS, driving excess androgen production, menstrual disruption and metabolic risks.
  • Lifestyle changes—balanced diet, regular exercise and modest weight loss—are the foundation of management.
  • Medications like metformin and inositols can further improve insulin sensitivity and reproductive health.
  • Early diagnosis and ongoing monitoring reduce the risk of diabetes, cardiovascular disease and other complications.
  • Use tools like the Ubie Symptom Checker to evaluate your symptoms and guide discussions with your healthcare provider.

Understanding how insulin resistance affects PCOS empowers you to take proactive steps toward better health. Speak to your doctor about the best plan for your individual needs.

(References)

  • * Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012 Dec;33(6):981-1030. doi: 10.1210/er.2011-1034. Epub 2012 Oct 12. PMID: 23065822; PMCID: PMC5393155.

  • * Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 2018 Sep;86:33-43. doi: 10.1016/j.metabol.2017.09.016. Epub 2017 Oct 10. PMID: 29024702.

  • * Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018 Sep;182:27-36. doi: 10.1016/j.jsbmb.2018.04.008. Epub 2018 Apr 17. PMID: 29678491.

  • * Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020 Mar;502:214-221. doi: 10.1016/j.cca.2019.11.003. Epub 2019 Nov 13. PMID: 31733195.

  • * Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B. Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int J Mol Sci. 2021 Apr 6;22(7). doi: 10.3390/ijms22073789. Epub 2021 Apr 6. PMID: 33917519; PMCID: PMC8038770.

  • * Calcaterra V, Verduci E, Cena H, Magenes VC, Todisco CF, Tenuta E, Gregorio C, De Giuseppe R, Bosetti A, Di Profio E, Zuccotti G. Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients. 2021 May 28;13(6). doi: 10.3390/nu13061848. Epub 2021 May 28. PMID: 34071499; PMCID: PMC8228678.

  • * Xu Y, Qiao J. Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature. J Healthc Eng. 2022;2022:9240569. doi: 10.1155/2022/9240569. Epub 2022 Mar 21. PMID: 35356614; PMCID: PMC8959968.

  • * Gu Y, Zhou G, Zhou F, Wu Q, Ma C, Zhang Y, Ding J, Hua K. Life Modifications and PCOS: Old Story But New Tales. Front Endocrinol (Lausanne). 2022;13:808898. doi: 10.3389/fendo.2022.808898. Epub 2022 Apr 13. PMID: 35498415; PMCID: PMC9045543.

  • * Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023 Jan 11;16(1):9. doi: 10.1186/s13048-022-01091-0. Epub 2023 Jan 11. PMID: 36631836; PMCID: PMC9832677.

  • * Saleh FL, Starkman H, Furness A, Pfeifer SM, Kives S. Polycystic Ovary Syndrome in Adolescents. Obstet Gynecol Clin North Am. 2024 Dec;51(4):679-693. doi: 10.1016/j.ogc.2024.08.005. Epub 2024 Sep 20. PMID: 39510738.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.